|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Multifocal Motor Neuropathy | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Neuritis | |||||
| 3 | More general conditions related to this trial | ||||
| Nervous System Diseases | |||||
| Neuromuscular Diseases | |||||
| Peripheral Nervous System Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Immune Globulin Intravenous, 10% | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Immunoglobulins | |||||
| Immunoglobulins, Intravenous | |||||
| Rho(D) Immune Globulin | |||||
| 6 | More general drug interventions related to this trial | ||||
| Immunologic Factors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 7 | Sponsors listed in this trial | ||||
| Baxter Healthcare Corporation | |||||